Insurance regulators follow Blues' money trail

Article Abstract:

State insurance regulators express concern about management of the new investor-owned health insurance companies formed by mergers with Blue Cross & Blue Shield organizations. Consumer protection advocates question high compensation of executives in such companies as Blue Cross of California. According to some regulators, profit-making corporations should be required to set up charitable trusts with the assets gained from acquiring nonprofit health providers.

Insurance Regulation ex Auto-State, Mergers, acquisitions and divestments, Compensation and benefits, Nonprofit organizations, Blue Cross of California

---

Bill seeks equal mental health insurance coverage

Article Abstract:

The Senate has passed an amendment which would prohibit insurance discrimination against employees with mental illnesses. The "mental health parity" amendment would increase health insurance premiums in the private-sector by about 4% per year, according to the Congressional Budget Office. Medicare and Medicaid would be exempt from the mandate due to costs.

Specialty outpatient clinics, not elsewhere classified, Outpatient Mental Health and Substance Abuse Centers, Mental Health Care, Insurance Regulation, Social policy, Mental health services, Private sector, United States. Congress. Senate, Insurance, Mental health benefits

---

Similar abstracts:

• Abstracts: Boost for insurance reform. Employer survey predicts growing ranks of uninsured. Much ado about Medicaid: formula dispute threatens block-grant reform; middle-class revolt also feared
• Abstracts: Alabama ERISA decision a setback for state reform. Getting health insurance remains a problem for millions. Number of uninsured down slightly in '94 to 39.4 million
• Abstracts: Band practice. Be your own personal trainer
• Abstracts: Managed care files pose privacy risks: patients object to electronic mental health records. Employers look to managed care to rein in benefit costs
• Abstracts: FDA reform bill seen as delicate balance of speed, safety. Dr. Kessler leaving as FDA chief; strong replacement urged

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.